This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nakamura, H. Articles by Hirose, M. Search for Related Content PubMed PubMed Citation Articles by Nakamura, H. Articles by Hirose, M. Social Bookmarking                         What's this?

Enhancing Effects of Oltipraz on the Development of Spontaneous Hepatic Lesions in LEC Rats

Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan

Kazushi Okazaki

Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan

Akiyoshi Nishikawa

Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan, nishikaw{at}nihs.go.jp

Fumio Furukawa

Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan

Ken-Ichiro Kasahara

Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan

Makoto Miyauchi

Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan

Takayoshi Imazawa

Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan

Koji Uchida

Nagoya University Graduate School of Bioagricultural Sciences, Nagoya 464-8601, Japan

Masao Hirose

Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan

Oltipraz, developed as an antischistosomal agent, protects against the hepatotoxicity of many xenobiotics and is known to be an effective inhibitor of experimental carcinogenesi s in rodents. In the present study, we investigated its effects on the development of lesions in LEC rats, established as a mutant strain characterized by a hereditary predisposition for hepatic damage with severe jaundice. A total of 35 male 6-week-old LEC rats were divided into 2 groups, one administered diet supplemented with oltipraz at a dose of 400 ppm, and the other fed basal diet alone. Animals in each group were sequentially sacrificed at 10, 15, and 25 weeks after commencement of the oltipraz administration. Eight animals died or became moribund in the oltipraz group during weeks 10 and 11 of the treatment, whereas only one rat in the nontreatment group died after 16 weeks. All dead or moribund animals showed severe or moderate jaundice. The treatment caused a decrease in body weight gain from 9 to 13 weeks, and an increase in relative liver weight at each sacrifice point. Serum biochemical assays performed at week 25 revealed elevated levels of serum AST, ALT, LDH, ALP, -GTP, and Cu in the treated-animals. The glutathione level in the livers of oltipraz-treated animals was significantly higher than that in the control rats. Histopathologically, enlarged hepatocytes with large nuclei, focal necrosis, pigment granule-laden Kupffer cells and hypertrophy of renal tubule cells were observed in both groups, but the severity of these changes was greater in the oltipraz group. Our results thus indicate that spontaneous hepatic damage in LEC rats is enhanced by oltipraz, by a mechanism that remains to be elucidated.

Key Words: Oltipraz • LEC rat • hepatitis.

References

• Ansher S., Dolan P., Bueding E. (1986). Biochemical effects of dithiolthiones. Food Chem Toxicol 24: 405—415.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ansher SS, Dolan P., Bueding E. (1983). Chemoprotective effects of two dithiolthiones and of butylhydroxyanisol e against carbon tetrachloride and acetaminophen toxicity. Hepatology 3: 932—935.[Web of Science][Medline] [Order article via Infotrieve]
• Archer S. (1985). The chemotherapy of schistosomiasis. Ann Rev Pharmacol 25: 485—508.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bueding E., Dolan P., Leroy J-P. (1982). The antischistosomal activity of oltipraz. Res Commun Chem Pathol Pharmacol37: 293—303.[Web of Science][Medline] [Order article via Infotrieve]
• Buetter TM, Gallagher EP, Wang C., Stahl DL, Hayes JD, Eaton DL (1995). Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol Appl Pharmacol 135: 45—57.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Clapper ML, Wood M., Leahy K., Lang D., Miknyoczki S., Ruggery A. (1995). Chemopreventive activity of oltipraz against N-nitrosobis(2-oxopropyl)amine (BOP)-induced ductal pancreatic carcinoma development and effects on survival of Syrian golden hamsters. Carcinogenesis 16: 2159— 2165.[Abstract/Free Full Text]
• Hissin PJ, Hilf R. ( 1976). A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 27: 214—226.
• Jacobson LP, Zhang B-C., Zhu Y-R., Wang J-B., Wu Y., Zhang Q-N., Yu L-Y., Qian G-S., Kuang S-Y., Li Y-F., Fang X., Zarba A., Chen B., Enger C., Davidson NE, Gorman MB, Gordon GB, Prochaska HJ, Egner PA, Groopman JD, Munoz A., Helzlsouer KJ, Kensler TW (1997). Oltipraz chemoprevention trial in Qidong, People's Republic of China: Study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev 6: 257—265.[Abstract]
• Jocelyne A-F., Karine M., Martine C., Marie-Pierre D., Fabrice M., Andre G., Pierre C., Josiane C. (1997). Oltipraz stimulates the transcription of the manganese superoxide dismutase in rat hepatocytes. Carcinogenesis 18: 2113— 2117.[Abstract/Free Full Text]
• Kensler TW, Egner PA, Trush MA, Bueding E., Groopman JD (1985). Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxiquin and a dithiolthione. Carcinogenesis 6: 759—763.[Abstract/Free Full Text]
• Kensler TW, Groopman JD, Sutter TR, Curphey TJ, Roebuck BD (1999). Development of cancer chemopreventive agents: Oltipraz as a paradigm. Chem Res Toxicol 12: 113—126.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kensler TW, He X., Otieno M., Egner PA, Jacobson LP, Chen B., Wang J-S., Zhu Y-R., Zhang B-C., Wang J-B., Wu Y., Zhang Q-N., Qian G-S., Kuang S-Y., Fang X., Li Y-F., Yu L-Y., Prochaska HJ, Davidson NE, Gordon GB, Gorman MB, Zarba A., Enger C., Munoz A., Helzlsover KJ, Groopman JD (1998). Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol Biomarkers Prev 7: 127—134.[Abstract]
• Kensler TW, Helzlsouer KJ (1995). Oltipraz: Clinical opportunities for cancer chemoprevention. J Cell Biochem (Suppl) 22: 101—107.[CrossRef]
• Koizumi M., Fujii J., Suzuki K., Inoue T., Inoue T., Gutteridge JMC, Taniguchi N. (1998). A marked increase in free copper levels in the plasma and liver of LEC rats: An animal model for Wilson disease and liver cancer. Free Rad Res 28: 441—450.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Krezel A., Bal W. (1999). Coordination chemistry of glutathione. Acta Biochim Pol 46: 567—580.[Web of Science][Medline] [Order article via Infotrieve]
• Li Y., Togashi Y., Sato S., Emoto T., Kang J-H., Takeichi N., Kobayashi H., Kojima Y., Une Y., Uchino J. (1991a). Abnormal copper accumulation in non-cancerous and cancerous liver tissues of LEC rats developing hereditary hepatic damage and spontaneous hepatoma. Jpn J Cancer Res 82: 490—492.[CrossRef][Web of Science]
• Li Y., Togashi Y., Sato S., Emoto T., Kang J-H., Takeichi N., Kobayashi H., Kojima Y., Une Y., Uchino J. (1991b). Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J Clin Inv 87, 1858—1861.[Web of Science][Medline] [Order article via Infotrieve]
• Li Y., Trush MA (1994). Reactive oxygen-dependen t DNA damage resulting from the oxidation of phenolic compounds by a copper-redox cycle mechanism. Cancer Res (Suppl) 54: 1895s—1898s.[Abstract/Free Full Text]
• Meyer DJ, Harris JM, Gilmore KS, Coles B., Kensler TW, Ketterer B. (1993). Quantitation of tissue- and sex-specific induction of rat GSH transferase subunits by dietary 1,2-dithiole-3-thiones. Carcinogenesis 14: 567— 572.[Abstract/Free Full Text]
• Muramatsu Y., Yamada T., Moralejo DH, Suzuki Y., Matsumoto K. (1994). Wilson's disease gene is homologous to hts causing abnormal copper transport in Long-Evans Cinnamon rats. Gastroenterology 107: 1189— 1192.[Medline] [Order article via Infotrieve]
• Nishikawa A., Tanakamaru Z., Furukawa F., Lee IS, Kasahara K., Ikezaki S., Takahashi M. (1998). Chemopreventive activity of oltipraz against induction of glandular stomach carcinogenesi s in rats by N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis 19: 365—368.[Abstract/Free Full Text]
• Oikawa S., Yamada K., Yamashita N., Tada-Oikawa S., Kawanishi S. (1999). N-Acetylcysteine, a cancer chemopreventive agent, causes oxidative damage to cellular and isolated DNA. Carcinogenesis 20: 1485—1490.[Abstract/Free Full Text]
• Rao CV, Rivenson A., Zang E., Steele V., Kelloff G., Reddy BS (1996). Inhibition of 2-amino-1-methyl-6-phenylimidaz o[4,5]pyridine-induced lymphoma formation by oltipraz. Cancer Res 56: 3395—3398.[Abstract/Free Full Text]
• Rao CV, Tokomo K., Kelloff G., Reddy BS (1991). Inhibition by dietary oltipraz of experimental intestinal carcinogenesi s induced by azoxymethan e in male F344 rats. Carcinogenesis 12: 1051—1055.[Abstract/Free Full Text]
• Salid Ahmad M., Fazal F., Rahman A., Hadi SM, Parish JH (1992). Activities of flavonoids for the cleavage of DNA in the presence of Cu(II): Correlation with generation of active oxygen species. Carcinogenesis 13: 605—608.[Abstract/Free Full Text]
• Sasaki M., Yoshida MC, Kagami K., Takeichi N., Kobayashi H., Dempo K., Mori M. ( 1985). Spontaneous hepatitis in an inbred strain of Long Evans rats. Rat News Lett 14, 4—6.
• Suemizu H., Yoshimura S., Takeichi N., Moriuchi T. (1994). Decreased expression of liver glutathione peroxidase in Long-Evans cinnamon mutant rats predisposed to hepatic damage and hepatoma. Hepatology 19: 694— 700.[Web of Science][Medline] [Order article via Infotrieve]
• Wang JS, Shen X., Zhu YR, Zhang BC, Wang JB, Qian GS, Kuang SY, Zarba A., Egner PA, Jacobson LP, Munoz A., Helzlsouer KJ, Groopman JD, Kensler TW (1999). Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst 91: 347—354.[Abstract/Free Full Text]
• Wu J., Forbes JR, Chen HS, Cox DW (1994). The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet 7: 541—545.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Yoshida MC, Masuda R., Sasaki M., Takeichi N., Dempo K., Mori M. ( 1987). New mutation causing hereditary hepatitis in the laboratory rat. J Hered 78: 361—365.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 30, No. 2, 173-177 (2002)
DOI: 10.1080/019262302753559506


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Y. Kitamura, A. Nishikawa, H. Nakamura, F. Furukawa, T. Imazawa, T. Umemura, K. Uchida, and M. Hirose Effects of N-Acetylcysteine, Quercetin, and Phytic Acid on Spontaneous Hepatic and Renal Lesions in LEC Rats Toxicol Pathol, August 1, 2005; 33(5): 584 - 592. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nakamura, H. Articles by Hirose, M. Search for Related Content PubMed PubMed Citation Articles by Nakamura, H. Articles by Hirose, M. Social Bookmarking                         What's this?